Sentences with phrase «general hospital cancer»

I used both skills doing volunteer work for hospital groups, and have served on the Board of Directors of the Friends of the Massachusetts General Hospital Cancer Center and on the MGH's Women's Cancer Advisory Board.

Breast cancer survivors may be less likely to develop coronary heart disease for two reasons, says Elizabeth Lamont, MD, an assistant professor at Massachusetts General Hospital Cancer Center and Harvard Medical School.

Among her arm - long list of awards are the 2010 AACR Clowes Memorial Award, the 2008 Massachusetts General Hospital Cancer Center Prize, the 2005 NIH Director's Pioneer Award, the 2004 Charlotte Friend Memorial Award from the AACR, and the first Paul Marks Prize for Cancer Research, in 2001.

Daniel Haber, director of the Massachusetts General Hospital Cancer Center, said it is beside the point to focus on the specific percentage of cancer risk contributed by random errors, environmental factors and heredity.

Maus - a former Penn faculty member who is now the Director of Cellular Immunotherapy at the Massachusetts General Hospital Cancer Center and an assistant professor of Medicine at Harvard Medical School - is the senior author on the study.

Commenting on the trial, Dr Alice Shaw, director of thoracic oncology at the Massachusetts General Hospital Cancer Centre in Boston, US, said: «This is the first randomised study to examine how a second generation ALK inhibitor compares to standard second line chemotherapy in ALK positive patients who failed the standard first line therapy, which currently is crizotinib.»

Collaborations between industry and oncology researchers and clinicians are common, yet create challenges and opportunities for the oncology community to address,» write Ryan D. Nipp, M.D., and Beverly Moy, M.D., M.P.H., of the Massachusetts General Hospital Cancer Center, Boston, in a related commentary.

These genetic mutations can fluctuate over time, and some patients can harbor more than one mutation,» said Zofia Piotrowska, MD, lead author of the study and a thoracic oncologist at the Massachusetts General Hospital Cancer Center in Boston.

Jeffrey Settleman of the Massachusetts General Hospital Cancer Center in Charlestown and his colleagues treated tumour cells with cancer drugs.

Not exact matches

While still a PhD student, Massachusetts General Hospital pegged him to help optimize their cancer radiation treatments.

On any given day, Canada's leading researchers unravel the mysteries of biology in state - of - the - art labs throughout the Toronto Medical Discovery Tower and the Ontario Institute for Cancer Research; early - stage science and technology companies put business plans into action in the MaRS Incubator; organizations across the innovation spectrum grow their businesses in the Heritage Building — the original brick façade of the old Toronto General Hospital.

Arianna Grace Marsicek of Arlington Heights died of cancer Oct. 21 in Lutheran General Hospital, Park Ridge.

Flowers appreciated, or memorial contributions may be made to Cancer Patient Support Services Fund, Account # 0973, Cancer Care Center, Lutheran General Hospital, 1700 Luther Ln., Park Ridge, IL 60068 or American Diabetes Assoc. Memorial Program / NCC, PO Box 2680, North Canton, OH 44720.

In lieu of flowers contributions to the Disabled Jockey's Endowment, C / O Don Farrar, Chairman, 1540 S. Louis St., Anaheim, CA 92805 - 6423, Cancer Center at Lutheran General Hospital, 1775 Dempster, Park Ridge, 60068 or to St. Peter Lutheran Church, appreciated.

Take the new NHS rights to see a cancer specialist within 2 weeks of diagnosis, and a maximum waiting time for general treatments of 18 weeks, with the systems of redress such as getting treated in a private hospital if the NHS trusts can't get you treated in time.

UB's teaching hospitals include Buffalo General Hospital, the Erie County Medical Center (ECMC), Millard Fillmore Hospital, Roswell Park Cancer Institute and Veterans Affairs Western New York Health Care System.

Beau Biden, the attorney general of Delaware, is being tested at MD Anderson, a world renowned cancer treatment hospital, a source told CNN on Tuesday.

He completed training in Internal Medicine at Massachusetts General Hospital and in Oncology at the National Cancer Institute.

Researchers led by Patricia Donahoe and Xiaolong Wei of Massachusetts General Hospital and Harvard Medical School found that the common chemotherapy agent doxorubicin actually encourages the growth of ovarian cancer stem cells.

The findings by a team of Massachusetts General Hospital (MGH) investigators, which will be published in the April 24 issue of Cell and are receiving advance online release, support the importance of epigenetics — processes controlling whether or not genes are expressed — in cancer pathology and identify molecular circuits that may be targeted by new therapeutic approaches.

Dr Priscilla Brastianos, MD, a neuro - oncologist and Director of the Brain Metastasis Program at Massachusetts General Hospital, Boston, USA, will say: «Brain metastases are a devastating complication of cancer.

In a study recently published in the journal Nature Biotechnology, HSCI researchers at Harvard University and Massachusetts General Hospital (MGH), in collaboration with Boston Children's Hospital and Dana Farber Cancer Institute, have developed a non-toxic transplantation procedure using antibodies to specifically target blood stem cells in mice, an approach they hope will make blood stem cell transplants for these patients far less toxic.

says David Fisher, a cancer biologist at Massachusetts General Hospital in Boston.

In January, Jeffrey Engelman, a thoracic oncologist at Massachusetts General Hospital in Boston, and his colleagues detailed the case of a 52 - year - old woman with metastatic lung cancer in The New England Journal of Medicine.

The research team comprises representatives from National Cancer Centre Singapore (NCCS), Singapore General Hospital (SGH), Duke - NUS Graduate Medical School (Duke - NUS), A * STAR's Genome Institute of Singapore (GIS) and Cancer Science Institute Singapore (CSI Singapore) of the National University of Singapore (NUS).

Massachusetts General Hospital (MGH) investigators have identified the first potential molecular treatment target for the most common form of pancreatic cancer, which kills more than 90 percent of patients.

Circulating tumor cell (CTC) clusters — clumps of from 2 to 50 tumor cells that break off a primary tumor and are carried through the bloodstream — appear to be much more likely to cause metastasis than are single CTCs, according to a study from investigators at the Massachusetts General Hospital (MGH) Cancer Center.

Besides main collaborator National Cancer Centre Singapore (NCCS), this multi-national, multi-institutional project also involved National University of Singapore, Singapore General Hospital, and Duke - NUS Medical School from Singapore; Fundeni Clinical Institute from Romania; Khon Kaen University from Thailand; and Massachusetts General Hospital and Harvard Medical School from the United States.

In a letter to the New England Journal of Medicine, a Massachusetts General Hospital (MGH) research team reports a remarkable treatment response in a patient participating in a clinical trial of a novel immune - system - based cancer therapy.

Trials of the vaccine therapy are planned to start later this year at Massachusetts General Hospital in Boston, Johns Hopkins Medical Center in Baltimore, the Queensland Institute of Medical Research (QIMR) in Brisbane and the Royal Netherlands Cancer Institute in Amsterdam.

A research group at Boston's Massachusetts General Hospital, led by Tayyaba Hasan, has used nanocells and photodynamic therapy (light - activated chemicals) to target pancreatic cancer.

Commenting on the findings, Prof Robert Pirker, programme director for lung cancer at the Vienna General Hospital in Vienna, Austria, not involved in the study, said: «This subgroup analysis shows that the effect of necitumumab was slightly greater in patients with EGFR expressing tumours than it was in the entire SQUIRE population.

«By helping us understand that lower levels of RNF125 confer resistance to BRAF inhibitors, we have a new strategy to stratify patients for currently approved therapy versus participation for human clinical trials to investigate whether targeting JAK1 will be more effective in patients whose tumors exhibit reduced RNF125,» said Keith T. Flaherty, M.D., associate professor, Harvard Medical School, and director of Developmental Therapeutics, Cancer Center, Massachusetts General Hospital, and co-author of the study.

Co-authors on the study were Christian Mosimann (University of Zürich), Zi Peng Fan (Whitehead Institute and MIT), Justin Tan (Genome Institute of Singapore), Richard White (Memorial Sloan Kettering Cancer Center), Dominick Matos (Massachusetts General Hospital), Ann - Christin Puller (University Medical Center Hamburg - Eppendorf, Germany), Eric Liao (Harvard Stem Cell Institute and MGH) Richard Young (Whitehead Institute and MIT), and, at Boston Children's Hospital, Song Yang, Andrew Thomas, Julien Ablain, Rachel Fogley, Ellen van Rooijen, Elliott Hagedorn, Christie Ciarlo and Cristina Santoriello.

The first long - term study of a pioneering endoscopic laser treatment for early vocal - cord cancer, developed at Massachusetts General Hospital (MGH) and previously shown to provide optimal voice outcomes, finds that it is as successful as traditional approaches in curing patients» tumors while avoiding the damage to vocal quality caused by radiotherapy or by conventional laser or cold - instrument surgery.

The team is now working with doctors at Massachusetts General Hospital, who hope to use the new, noninvasive technique to study cells involved in cancer, asthma, and other conditions in which cell properties change as a disease progresses.

Harvard Stem Cell Institute scientists at Massachusetts General Hospital have devised a new way to use stem cells in the fight against brain cancer.

Researchers at Taichung Veterans General Hospital in Taichung, Taiwan; E ‐ Da Hospital in Kaohsiung, Taiwan; Fu Jen Catholic University in New Taipei City, Taiwan; and National Taiwan University Hospital in Taipei conducted a nationwide cohort study to determine if aspirin therapy could, indeed, reduce liver cancer risk.

Preliminary results of a study of patients with prostate cancer show that MR tractography may be a reliable quantitative imaging biomarker to assess prostate cancer treatment response to androgen deprivation and radiation therapy, according to a team of researchers at Brigham and Women's Hospital and Massachusetts General Hospital in Boston.

«Liver cancer is the second leading cause of cancer death worldwide, and HBV is the most prevalent risk factor in our region, says Teng ‐ Yu Lee, MD, PhD, a researcher in the Department of Gastroenterology at Taichung Veterans General Hospital and lead investigator in the study.

Dr. Engelman is the principal investigator of his own laboratory at the Massachusetts General Hospital (MGH) Cancer Center, the director of thoracic oncology at MGH and the director of molecular therapeutics at the MGH Cancer Center.

Arizona State University Army Research Lab, Weapons and Materials Research Directorate Baylor School of Medicine Carnegie Mellon University Case Western Reserve University CIIT Centers for Health Research Columbia University Cornell University Emory University School of Medicine Fred Hutchinson Cancer Research Center J. David Gladstone Institute Harvard University Medical School Indiana University, Bloomington Johns Hopkins School of Medicine Los Alamos National Laboratory Lawrence Livermore National Laboratory Louisiana State University Health Sciences Center Massachusetts General Hospital Massachusetts Institute of Technology McGill University MCP Hahnemann Medical School Medical College of Georgia Medical College of Wisconsin Microsoft NCI NIEHS NIH NOAA New York University School of Medicine Penn State University College of Medicine Pfizer Rockefeller University Rowland Institute for Science Seattle Biomedical Research Institute St. Jude Children's Research Hospital Stanford University USEPA / National Risk Management Research Lab University of Alabama, Birmingham University of California, Berkeley University of California, Los Angeles University of California, San Diego University of California, San Francisco University of Chicago University of Cincinnati College of Medicine University of Colorado at Boulder University of Georgia University of Illinois, Chicago University of Illinois, Urbana - Champagne University of Maryland University of Medicine and Dentistry of New Jersey University of Michigan University of Minnesota University of New Mexico University of North Carolina, Chapel Hill University of Pennsylvania University of Rochester School of Medicine and Dentistry University of Texas, Austin University of Texas Medical Branch University of Toronto University of Wisconsin, Madison Vanderbilt University Virginia Tech Yale University

«If we could build a «family tree» of all cancer nodules in a patient, we could determine how different tumors are related to each other and reconstruct how the cancer evolved,» says Kamila Naxerova, PhD, of the Steele Laboratory for Tumor Biology at Massachusetts General Hospital (MGH), corresponding author of the report being published in PNAS Early Edition.

Massachusetts General Hospital (MGH) investigators have identified a way in which a type of lung cancer co-opts a portion of the immune system to increase tumor progression.

More than one - third of centres (36 %) were tertiary care cancer centres and 22 % were tertiary care general hospitals.

This latest study, which cross-linked 23,201 female cancer survivors from the Scottish Cancer Registry with hospital discharge records, revealed 6627 pregnancies among the cancer survivors when nearly 11,000 would have been expected in a comparable matched control group from the general populcancer survivors from the Scottish Cancer Registry with hospital discharge records, revealed 6627 pregnancies among the cancer survivors when nearly 11,000 would have been expected in a comparable matched control group from the general populCancer Registry with hospital discharge records, revealed 6627 pregnancies among the cancer survivors when nearly 11,000 would have been expected in a comparable matched control group from the general populcancer survivors when nearly 11,000 would have been expected in a comparable matched control group from the general population.

A team of researchers at the Massachusetts General Hospital and Harvard Medical School in Boston has developed technologies for precision measurement of cell migration speed before and applied the new tool to study the variations of migration speed in population of cancer cells.

Dr Jeremy Thomas, a consultant pathologist at the Western General Hospital, Edinburgh, UK, told the European Breast Cancer Conference that although the majority of women with DCIS received the correct surgery for their disease, large numbers of women were undergoing mastectomy for DCIS either as a result of failed breast conservation surgery or for tumors that turned out to be smaller than 20 mm in diameter and therefore should normally have had a lumpectomy rather than a mastectomy.

He completed his internal medicine residency at Massachusetts General Hospital and his hematology / oncology fellowship at Dana - Farber / Partners Cancer Care.

A study from investigators at the Massachusetts General Hospital (MGH) Cancer Center has, for the first time, identified genomic differences between the breast tumors of African American and white women, differences that could contribute to the recognized differences in recurrence rate and survival.